PTPN13 and cancer: Furthermore, SHROOM4 appears to regulate the tumor microenvironment (TME) through mechanisms such as angiogenesis and cell cycle modulation mediated by ANGPTL7 and PTPN13 in LUAD, thereby influencing cancer progression.